| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
77 ANGIOGENESIS IN INDOLENT NON-HODGKIN'S LYMPHOMA (NHL)
|
Minoia, C.
|
|
2010
|
36 |
Supplement 1 |
p. S117-S118
2 p.
|
artikel
|
| 2 |
2 A NON COMMON BRAF MUTATION, c.1799-1801delTGA, IDENTIFIED IN SPORADIC COLORECTAL CANCER OF SICILIAN PATIENT
|
Bruno, L.
|
|
2010
|
36 |
Supplement 1 |
p. S95-
1 p.
|
artikel
|
| 3 |
Approach to radiation therapy in hepatocellular carcinoma
|
Ma, Shumei
|
|
2010
|
36 |
Supplement 1 |
p. 157-163
7 p.
|
artikel
|
| 4 |
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
|
Araujo, John
|
|
2010
|
36 |
Supplement 1 |
p. 492-500
9 p.
|
artikel
|
| 5 |
36 DETECTION OF KRAS MUTATIONS IN COLORECTAL CARCINOMA PATIENTS WITH AN INTEGRATED PCR/SEQUENCING AND REAL TIME PCR APPROACH
|
Carotenuto, P.
|
|
2010
|
36 |
Supplement 1 |
p. S105-
1 p.
|
artikel
|
| 6 |
1 ECHOCARDIOGRAPHIC MONITORING DURING ANTHRACYCLINE ADMINISTRATION IN PATIENTS WITH HODGKIN'S AND NON-HODGKIN'S LYMPHOMA: THE TEI-INDEX EVALUATION
|
Oliva, S.
|
|
2010
|
36 |
Supplement 1 |
p. S95-
1 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2010
|
36 |
Supplement 1 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2010
|
36 |
Supplement 1 |
p. IFC-
1 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2010
|
36 |
Supplement 1 |
p. i-
1 p.
|
artikel
|
| 10 |
33 EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE
|
Amodeo, V.
|
|
2010
|
36 |
Supplement 1 |
p. S104-S105
2 p.
|
artikel
|
| 11 |
Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer
|
Abbotts, Rachel
|
|
2010
|
36 |
Supplement 1 |
p. 425-435
11 p.
|
artikel
|
| 12 |
Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
|
De Vita, F.
|
|
2010
|
36 |
Supplement 1 |
p. S11-S15
5 p.
|
artikel
|
| 13 |
50 IMPLEMENTATION OF ADHERENCE TO ERLOTINIB (E) AS SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC)
|
Gebbia, V.
|
|
2010
|
36 |
Supplement 1 |
p. S110-
1 p.
|
artikel
|
| 14 |
Lapatinib in breast cancer: clinical experiences and future perspectives
|
Giampaglia, M.
|
|
2010
|
36 |
Supplement 1 |
p. S72-S79
8 p.
|
artikel
|
| 15 |
Male breast cancer
|
Gómez-Raposo, César
|
|
2010
|
36 |
Supplement 1 |
p. 451-457
7 p.
|
artikel
|
| 16 |
Metastasis and bone loss: Advancing treatment and prevention
|
Coleman, Robert E.
|
|
2010
|
36 |
Supplement 1 |
p. 615-620
6 p.
|
artikel
|
| 17 |
New molecular targets in bone metastases
|
Santini, D.
|
|
2010
|
36 |
Supplement 1 |
p. S6-S10
5 p.
|
artikel
|
| 18 |
67 OPTIMIZATION OF THE THERAPEUTIC RATIO IN CANCER THERAPY: THE INTERACTION BETWEEN DRUGS, MOLECULAR TARGETS AND RADIATIONS
|
Santoro, M.
|
|
2010
|
36 |
Supplement 1 |
p. S114-S115
2 p.
|
artikel
|
| 19 |
5 PANITUMUMAB PLUS CHEMOTHERAPY AS SALVAGE TREATMENT IN PRETREATED ADVANCED COLORECTAL CANCER PATIENTS: A SINGLE INSTITUTION'S EXPERIENCE
|
Giuliani, F.
|
|
2010
|
36 |
Supplement 1 |
p. S96-
1 p.
|
artikel
|
| 20 |
Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers
|
Powell, C.
|
|
2010
|
36 |
Supplement 1 |
p. 566-575
10 p.
|
artikel
|
| 21 |
Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab
|
Seront, Emmanuel
|
|
2010
|
36 |
Supplement 1 |
p. S11-S14
4 p.
|
artikel
|
| 22 |
Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
|
van de Velde, C.J.H.
|
|
2010
|
36 |
Supplement 1 |
p. 54-62
9 p.
|
artikel
|
| 23 |
19 THE IMPORTANCE OF A CAREFUL CARDIOLOGIC FOLLOW UP IN BREAST CANCER SURVIVORS: PRELIMINARY DATA OF AN OBSERVATIONAL STUDY
|
Galluci, G.
|
|
2010
|
36 |
Supplement 1 |
p. S100-
1 p.
|
artikel
|
Tijdschrift beschrijving